MedPage Today on MSN
Real-World Data Show Gout Treatment Disparities
In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...
What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains four additional ...
A substantial percentage of adults with gout attribute their condition to lifestyle factors, which may lead to worse health outcomes and poorer SU control.
Teenage sprinting sensation Gout Gout is taking the track world by storm. Before graduating high school, the 18-year-old was ...
Ahmad Reda is one of the brightest prospects in Australian boxing. The 22-year-old Sydneysider is 7-0 as a professional and ...
TipRanks on MSN
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing
The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). On December 31, 2025, XORTX Therapeutics highlighted newly published, ...
Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
She gained weight after welcoming her son Reggie in September 2018 and shed the pounds once again with a combination of ...
Inside an Explorer reporter's long journey learning to scuba dive, to visit one of Lake Champlain's 300+ underwater shipwrecks.
Detailed price information for Protalix Biotherapeutics (PLX-A) from The Globe and Mail including charting and trades.
As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results